If you are wondering whether Illumina's current share price still reflects its long term potential, you are not alone in asking if the stock offers good value today. The shares last closed at ...

Artificial intelligence is once again fueling a scorching tech stock rally, but the rising tide is notably not lifting all ...

But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. The ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...

What Is Driving the Updated Illumina Price Target? Illumina's fair value estimate has been revised from about US$119.84 to about US$132.06 per share, based on slightly higher assumptions for revenue ...

Illumina shares rose after Medicare approved reimbursement for its FDA-approved cancer test, a move expected to drive growth.

Discover GRAIL’s MCED screening tests, Illumina’s divestiture impact, and an $8B valuation base with TAM upside tied to FDA ...

We recently compiled a list of the Top 10 Oncology Stocks to Buy Now. Illumina Inc. is another one of the best cancer stocks ...

Illumina currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader medical space are IDEXX ...

An announcement from Illumina ( (ILMN) ) is now available.

Illumina (ILMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.